This content is machine translated Peripheral arterial occlusive disease as a pandemic It is high time to act Arterial occlusive disease is a disease with multiple sites (coronary, cerebral, peripheral, and visceral). Cardiovascular risk factors must be treated aggressively even in the asymptomatic patient with PAOD. The pAVK…
View Post 3 min This content is machine translated Decrease of brain volume in multiple sclerosis Potential future parameter for therapy monitoring More and more is becoming known about the importance of decreasing brain volume in patients with multiple sclerosis. And this is not least thanks to steady progress in imaging techniques…
View Post 6 min This content is machine translated Highlights from the ECTRIMS Congress 2013 New therapeutic approaches and an exciting hypothesis on the pathogenesis From October 2-5, 2013, the 29th ECTRIMS (Congress of the European Committee for Research and Treatment in Multiple Sclerosis) and the 18th RIMS (Annual Conference of Rehabilitation in MS) were…
View Post 4 min This content is machine translated Primary CNS lymphoma Advanced MRI diagnostics (spectroscopy, DWI, PWI) and MRI-guided biopsy. Introduction: Primary CNS lymphomas, predominantly of the B-cell type, are rare tumors with a peak incidence in middle to older age. Conventional MRI examination yields essentially nonspecific findings of a…
View Post 7 min This content is machine translated Headache How difficult is the differential diagnosis? In an interview with InFo NEUROLOGIE & PSYCHIATRIE, Dr. med. Andreas R. Gantenbein, Head Physician of Neurology at the RehaClinic Bad Zurzach, provides information on the possible causes and trigger…
View Post 10 min This content is machine translated Occlusion therapy of intracranial aneurysms Endovascular and neurosurgical options. Aneurysmal subarachnoid hemorrhage (aSAB) is associated with high mortality and morbidity. After initial stabilization of the patient, neurosurgical and/or endovascular therapies must be used to eliminate the source of bleeding.…
View Post 5 min This content is machine translated Rehabilitation and long-term management in MS Are rehabilitative measures still necessary in MS today? Despite the introduction of disease-modulating pharmacological therapies, rehabilitative interventions continue to play an important role in the long-term management of MS. People with MS should be encouraged to engage in…
View Post 2 min This content is machine translated Thrust-remitting MS An update on basic oral therapy Several encouraging advances have been made in the treatment of relapsing-remitting multiple sclerosis (MS) in recent years. Thus, the first orally administered substance – fingolimod – now also has a…
View Post 4 min This content is machine translated 86th Congress of the German Society of Neurology Highlights from the DGN Congress 2013 This year’s meeting of the German Society of Neurology took place in Dresden from September 18-21, 2013. We have selected four exciting studies that were highlighted at this congress.
View Post 3 min This content is machine translated Approval Teriflunomide (Aubagio®) Significantly lower risk of disability progression The more a patient with MS is limited in different areas of life by his increasing disability, the worse his health status becomes. In Switzerland, an oral MS treatment, teriflunomide,…
View Post 2 min This content is machine translated An update Cochrane analysis compares eleven substances in MS The aim of a recent meta-analysis by the Cochrane Collaboration was to compare eleven agents used in relapsing-remitting multiple sclerosis (RRMS) in terms of reduction in relapse rates, disability progression,…
